Commentary: World Returns in Health Care Will Drive How Long You Live, But Your Country Will Stand in Your Way
Tomas Philipson’s latest Forbes.com Op-Ed examines how international linkages between health care economies will affect how long you and your kids will live.
Precision’s MacEwan Participates in The Network for Excellence in Health Innovation (NEHI) “On Call” Series
The Network for Excellence in Health Innovation (NEHI) held a special forum on August 19th, focusing on better use of medicines in diabetes, featuring the recent study and ADA presentation by Precision’s Joanna MacEwan. She discussed her recent work and fielded questions from the NEHI membership– exploring the implications of new research on the use of diabetes medications and what it means for health care delivery reform, insurance benefit design, changes in health care payment and other critical policy issues.
Commentary: Dying to Live – Why Is Health Care So Valuable in the Face of Death?
Tomas Philipson’s latest Forbes.com Op-Ed examines end of life care, and why health care is so valuable in the face of death.
Commentary: Big Data Analytics: The Next Evolution in Drug Development
Precision’s Deb Phippard, PhD, and Jared Kohler, PhD, address the potential of Big Data, analytics, and technology to increase efficiency and decrease costs in the drug development process in a guest column for Bioprocess Online. Read the full article here:
Commentary: The California Child Vaccination Mandates and the Everlasting Cycle of Infectious Diseases
Precision’s Tomas Philipson’s latest Forbes.com Op-Ed examines California’s recently enacted vaccination mandate, and the application of economic epidemiology.